1. Home
  2. XNCR vs HMN Comparison

XNCR vs HMN Comparison

Compare XNCR & HMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • HMN
  • Stock Information
  • Founded
  • XNCR 1997
  • HMN 1945
  • Country
  • XNCR United States
  • HMN United States
  • Employees
  • XNCR N/A
  • HMN N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • HMN Property-Casualty Insurers
  • Sector
  • XNCR Health Care
  • HMN Finance
  • Exchange
  • XNCR Nasdaq
  • HMN Nasdaq
  • Market Cap
  • XNCR 1.7B
  • HMN 1.5B
  • IPO Year
  • XNCR 2013
  • HMN 1991
  • Fundamental
  • Price
  • XNCR $24.20
  • HMN $39.75
  • Analyst Decision
  • XNCR Strong Buy
  • HMN Hold
  • Analyst Count
  • XNCR 9
  • HMN 3
  • Target Price
  • XNCR $36.33
  • HMN $43.00
  • AVG Volume (30 Days)
  • XNCR 850.2K
  • HMN 230.4K
  • Earning Date
  • XNCR 11-06-2024
  • HMN 02-05-2025
  • Dividend Yield
  • XNCR N/A
  • HMN 3.44%
  • EPS Growth
  • XNCR N/A
  • HMN N/A
  • EPS
  • XNCR N/A
  • HMN 2.52
  • Revenue
  • XNCR $85,164,000.00
  • HMN $1,589,100,000.00
  • Revenue This Year
  • XNCR N/A
  • HMN N/A
  • Revenue Next Year
  • XNCR $89.22
  • HMN $7.77
  • P/E Ratio
  • XNCR N/A
  • HMN $15.70
  • Revenue Growth
  • XNCR N/A
  • HMN 10.71
  • 52 Week Low
  • XNCR $15.31
  • HMN $31.81
  • 52 Week High
  • XNCR $27.24
  • HMN $43.26
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 44.92
  • HMN 40.58
  • Support Level
  • XNCR $22.74
  • HMN $38.98
  • Resistance Level
  • XNCR $25.54
  • HMN $42.05
  • Average True Range (ATR)
  • XNCR 1.17
  • HMN 0.77
  • MACD
  • XNCR -0.33
  • HMN -0.39
  • Stochastic Oscillator
  • XNCR 22.00
  • HMN 14.66

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.

About HMN Horace Mann Educators Corporation

Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are 403(b) tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The company uses several former teachers in its salesforce. Its segments include Property and Casualty, Supplemental & Group Benefits, Life & Retirement, and Corporate and Other.

Share on Social Networks: